

Quviviq costs up to $680 without insurance. Learn how to save with copay cards, discount programs, patient assistance, and other strategies in 2026.
Quviviq (Daridorexant) is one of the newest and most innovative insomnia medications available. As a dual orexin receptor antagonist (DORA), it works differently from older sleep aids by blocking orexin — the brain chemical that keeps you awake — rather than sedating you through the GABA system.
The problem? Quviviq can cost $550 to $680 for a 30-day supply without insurance. That's more than $7,000 a year out of pocket. With no generic version available (and none expected until at least 2034), affordability is a real barrier for many patients.
The good news is there are several ways to bring that cost down significantly. In this guide, we'll walk through every option available to you in 2026.
Let's start with the baseline numbers:
These prices can vary by pharmacy. Chain pharmacies like CVS, Walgreens, and Rite Aid may charge different amounts, and even locations within the same chain can have different pricing.
The single best savings tool for most patients is the manufacturer's copay card from Idorsia Pharmaceuticals.
How it works:
How to get it:
Important limitations:
If you have commercial insurance, this should be your first stop. Going from a $100+ copay to $25 makes a huge difference.
If you don't have insurance or the copay card doesn't work for your situation, prescription discount cards can still provide meaningful savings.
GoodRx shows Quviviq prices starting around $135 at select pharmacies. Prices vary by location, so check multiple pharmacies on the GoodRx website or app. This represents a savings of $400 or more compared to full retail price.
SingleCare offers coupons for Quviviq that can reduce the price below the standard retail rate. Prices vary by pharmacy and location. Check singlecare.com for current pricing in your area.
Several other platforms may offer competitive pricing on Quviviq:
Tip: Always compare prices across multiple discount platforms and pharmacies. Pricing can vary by $100 or more for the same medication at different locations.
If you're uninsured or have significant financial hardship, patient assistance programs (PAPs) may be able to help you get Quviviq at reduced cost or free.
Idorsia's QUVIVIQ360 program offers more than just copay cards. The program can help patients navigate access challenges, including connecting patients with financial assistance resources. Contact QUVIVIQ360 through your prescriber or the Quviviq website.
NeedyMeds is a nonprofit that maintains a database of patient assistance programs, including those for insomnia medications. Search for "Daridorexant" or "Quviviq" to see available programs.
RxAssist provides a comprehensive database of patient assistance programs organized by drug and manufacturer. It can help you identify whether Idorsia or other organizations offer assistance for Quviviq.
RxHope connects patients with manufacturer and independent assistance programs. Your doctor's office can help you apply.
If you have insurance but Quviviq is still too expensive, there are strategies to improve your coverage:
If your insurance denied coverage for Quviviq, you have the right to appeal. Your doctor can submit additional documentation explaining why Quviviq is medically necessary for your specific case. Many denials are overturned on appeal.
If Quviviq is on a high formulary tier with a large copay, ask your insurance plan for a tier exception. Your doctor will need to provide clinical justification for why a lower-tier alternative isn't appropriate.
If your plan requires you to try other medications before covering Quviviq, and you've already tried and failed those medications, your doctor can document this to bypass the step therapy requirement.
If you take Quviviq regularly, it's worth checking formulary coverage during your next open enrollment period. Some plans may cover Quviviq at a lower tier than others.
Some insurance plans offer lower copays for medications filled through their mail-order pharmacy. This can be a particularly good option for Quviviq, as mail-order pharmacies are also more likely to have it in stock.
If your insurance allows it, filling a 90-day supply at once may reduce your per-month cost. Many plans offer a "3 months for the price of 2" benefit for mail-order fills.
Cash prices for Quviviq can vary by hundreds of dollars between pharmacies. Always compare prices before filling. Tools like Medfinder can help you find pharmacies with Quviviq in stock, and discount card platforms show pricing by location.
If Quviviq remains unaffordable despite these strategies, talk to your doctor about alternatives. Generic Zolpidem costs as little as $5 to $25 per month, and generic Eszopiclone costs about $10 to $40 per month. While they work differently than Quviviq, they may be effective for your insomnia. See our full comparison: Alternatives to Quviviq.
Quviviq is an effective insomnia treatment, but its high cost can be a real barrier. The manufacturer copay card ($25/month for eligible patients) is the best first option. Discount cards like GoodRx (starting around $135) can help cash-pay patients. And patient assistance programs exist for those with financial hardship.
Don't let cost prevent you from getting the sleep you need. Explore every option, compare prices, and work with your doctor to find the most affordable path to your medication.
Need to find Quviviq at a pharmacy near you? Use Medfinder to check real-time availability. And for more information about Quviviq itself, read our guides on what Quviviq is and how it works and Quviviq side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.